Online Only Articles

Impact of FLT3-ITD length on prognosis of acute myeloid leukemia

Suzhou Key laboratory for medical biotechnology, Suzhou Vocational Health College, Suzhou, China
Department of Hematological Malignancies Translational Science, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Department of Molecular Medicine, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Department of Hematological Malignancies Translational Science, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA, USA
Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China;Institute of Blood and Marrow Transplantation, Suzhou, China;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
Vol. 104 No. 1 (2019): January, 2019 https://doi.org/10.3324/haematol.2018.191809